|  Help  |  About  |  Contact Us

Publication : Proteomic pathways to metabolic disease and type 2 diabetes in the pancreatic islet.

First Author  Yau B Year  2021
Journal  iScience Volume  24
Issue  10 Pages  103099
PubMed ID  34622154 Mgi Jnum  J:314446
Mgi Id  MGI:6790549 Doi  10.1016/j.isci.2021.103099
Citation  Yau B, et al. (2021) Proteomic pathways to metabolic disease and type 2 diabetes in the pancreatic islet. iScience 24(10):103099
abstractText  Pancreatic islets are essential for maintaining physiological blood glucose levels, and declining islet function is a hallmark of type 2 diabetes. We employ mass spectrometry-based proteomics to systematically analyze islets from 9 genetic or diet-induced mouse models representing a broad cross-section of metabolic health. Quantifying the islet proteome to a depth of >11,500 proteins, this study represents the most detailed analysis of mouse islet proteins to date. Our data highlight that the majority of islet proteins are expressed in all strains and diets, but more than half of the proteins vary in expression levels, principally due to genetics. Associating these varied protein expression levels on an individual animal basis with individual phenotypic measures reveals islet mitochondrial function as a major positive indicator of metabolic health regardless of strain. This compendium of strain-specific and dietary changes to mouse islet proteomes represents a comprehensive resource for basic and translational islet cell biology.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

12 Bio Entities

0 Expression